Vandenberg, C. J., & Cory, S. (2013). ABT-199, a new Bcl-2–specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia. American Society of Hematology.
Citação norma ChicagoVandenberg, Cassandra J., and Suzanne Cory. ABT-199, a New Bcl-2–specific BH3 Mimetic, Has in Vivo Efficacy against Aggressive Myc-driven Mouse Lymphomas Without Provoking Thrombocytopenia. American Society of Hematology, 2013.
MLA引文Vandenberg, Cassandra J., and Suzanne Cory. ABT-199, a New Bcl-2–specific BH3 Mimetic, Has in Vivo Efficacy against Aggressive Myc-driven Mouse Lymphomas Without Provoking Thrombocytopenia. American Society of Hematology, 2013.
警告：這些引文格式不一定是100％准確.